Tag Archive for: NQ Eye Specialists

World Glaucoma Week (6th to 12th March 2022)

Amblyopia Awareness

Christmas Closure Dates

Merry Christmas from the team at NQ Eye Specialists! We will be closed from 12pm on Friday 21st December and will return at 9am on Monday 7th January. Thank you for your ongoing support in 2018. 

$80 million investment in eye medication

The Australian Government will invest $80 million in eye medications through the Pharmaceutical Benefits Scheme (PBS), effect from tomorrow.  Patients who suffer decreased vision as a result of blocked veins in the retina due to a condition known as retinal vein occlusion (RVO) are now able to access subsidised medication which is prescribed by their Ophthalmologist and injected into the eye.  Availability to treatment options such as these are vital to those patients suffering with poor and deteriorating vision due to RVO and other diseases of the eye.  Read more on this exciting news here:  http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt142.htm


The team at NQ Eye Specialists have been busy attending training with the Australian Society of Cataract and Refractive Surgeons. We were lucky enough to ride the wave in Noosa, to help provide our patients with the best possible outcomes. This conference enabled us to further our professional development with advice from the experts in Cataracts and Refractive surgery along with having the opportunity to engage with ophthalmology companies.



IPL Treatment for Dry Eye Disease

Dry eye disease is a multifactorial disease that comprises of many different components. Meibomian Gland Dysfunction is a condition where the glands that produce the top layer of your tear film become blocked. When the top layer of the tear film is compromised the tears evaporate, this is called Dry Eye. When the glands become blocked this leads to increased bacteria, leading to increased inflammation.

Intense Pulse Light was initially introduced in advanced Dermatology to treat numerous skin conditions. It has since been proven effective in treating various Dry eye conditions. This method uses brief powerful bursts of light at specific nanometre wavelengths to target change in blood vessels near the surface of the tear film. IPL works by these blood vessels absorbing heat, this mechanism is similar to hot compressing, enabling the pores of the glands to open up. A practitioner will then express the gland to remove the blocking matter. This application has resulted in improved symptoms such as less dryness, decreased use of lubricating eye drops, decrease in redness and foreign body sensation.

For more information please click the link below:



Dry eye

Corneal Cross-Linking

Keratoconus is a condition of the Cornea which causes the shape of the Cornea to change from a regular and spherical shape to a more conical shape. Collagen fibres within the cornea usually provide structure and strength to the cornea. In Keratoconus they are abnormal and cause the structure of the cornea to be weakened.  This can cause significant changes to vision, causing symptoms such as blurring of vision and bright lights appearing to be streaked.

NQ Eye Specialists now offer Corneal Collagen Cross-linking. This procedure is used to slow down or halt the progression of Keratoconus.

The procedure is performed under a topical anaesthetic. Firstly, the outer layer of the cornea is removed.  After this, Vitamin B2 drops are applied to the Cornea and the Cornea is then exposed to Ultra Violet light. This process causes a chemical reaction, resulting in an increased number of bonds between collagen fibres resulting in a strengthened Cornea.

Macular Degeneration Week 21-27 May 2018

May 21-27 is Macular Degeneration week. It is a week that allows us to reflect on all Australians suffering with Macula disease. This week increases awareness of all macula diseases including age-related Macular degeneration, Diabetic eye disease and other diseases of the macula. Macular degeneration is responsible for 50% of blindness across the general population. Prevention, detection and diagnosis is the key to achieving optimal eye health. Degeneration of the eye affects a special layer of the cell in the eye called the retinal pigment epithelium (RPE). In later stages of life, the RPE can die this can cause vision loss as there is a lack of blood supply to the eye.

There are two types of macular degeneration, dry and wet. Wet macular degeneration can be treated effectively through intravitreal injections in combination with laser or monotherapy. These do not cure the disease however they focus on maintaining and stabilising vision. Some clinical trials have been used to indicate vision improvement. Dr Goodwin has seen various positive outcomes associated with improved vision from the use of Intravitreal Injections.

For more information on this please click the link below:


World Glaucoma Week 2018

6 things you should know about Glaucoma